TTrialPathMatch Me to Trials
← Back to trials
RecruitingHearing Loss

The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents

Eligible age

12–18 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).

Sponsor: Oticon Medical

You may qualify if…

  • ✓ Subjects must meet the following criteria to be eligible for participation in the investigation:
  • ✓ 1. Signed Informed Consent Form (signed by parent or legal guardian and child).
  • ✓ 2. Subjects aged 12 to 17 years of age (inclusive)
  • ✓ 3. Subjects with the following audiometric criteria consistent with the current and approved labeling of the device:
  • ✓ 3.1 Conductive or mixed hearing loss with a pure tone average (PTA) bone conduction (BC) threshold (measured at 0.5, 1, 2, and 3 kHz) of the indicated ear better than or equal to 45 dB HL.
  • ✓ 3.2 OR subjects with a profound sensorineural hearing loss in one ear and normal hearing in the opposite ear (i.e., single-sided deafness or "SSD"). The pure tone average air conduction hearing (AC) thresholds of the hearing ear should be better than or equal to 20 dB HL (measured at 0.5, 1, 2, and 3 kHz).
  • ✓ 3.3 OR subjects who are indicated for an air-conduction contralateral routing of signals (AC CROS) hearing aid, but who for some reason cannot or will not use an AC CROS.
  • ✓ 4. Prior experience with amplified sound through properly fitted amplification devices such as a hearing aid, a CROS device, or a non-surgical bone conduction solution (e.g., a softband or sound arc).

You may not qualify if…

  • ✕ Subjects meeting any of the following criteria will not be permitted to participate in the investigation:
  • ✕ 1. Medical condition(s) that contraindicates implant surgery or anesthesia.
  • ✕ 2. Untreated ongoing middle ear infection at the time of surgery.
  • ✕ 3. Known or suspected contact allergy to silicone or other material used in the Sentio system.
  • ✕ 4. Insufficient bone quality/quantity/depth or skull size for implantation of a Sentio Ti implant, assessed according to clinical practice.
  • ✕ 5. Known conditions that could jeopardize wound healing and skin condition e.g. uncontrolled diabetes over time or skin or scalp condition(s) that may preclude attachment to, or interfere with usage of, the sound processor as judged by the investigator.
  • ✕ 6. Subject that has received radiotherapy in the area of implantation or is planned for such radiotherapy or similar during the investigation period.
  • ✕ 7. For bilateral asymmetric\* candidates, subjects already treated with a bone-anchored hearing solution on the side with the best BC thresholds.

Where it's recruiting

Georgia

Atlanta

Source: ClinicalTrials.gov · NCT06844071 · last updated 2025-09-22

The Sentio System: Post-market Evaluation of Safety and Performance in · TrialPath